journal article·2026-08Open access

3D-printed therapeutic lenses for sustained methylene blue delivery in ocular drug therapy

Murad Ali, Novan Rifky Lutfhyansyah, Shiv Dutt Purohit, Peter R. Corridon, Haider Butt

Abstract

Contact lenses are attractive platforms for sustained ocular drug delivery, but balancing drug loading, controlled release, and lens performance remains challenging. We developed an optically transparent 3D-printed hydrogel lens platform for controlled delivery of methylene blue (MB), a multifunctional antioxidant and antimicrobial dye. Using vat photopolymerization, HEMA-PEGDA hydrogels with varying monomer ratios were fabricated and compared with commercial silicone hydrogel lenses. Field-emission scanning electron microscopy (FEG-SEM) analysis showed continuous surface morphology in both clear and MB-loaded 3D-printed hydrogel samples, while XRD confirmed the crystalline nature of the MB starting material and the amorphous structure of the HEMA-PEGDA matrix. The printed lens-like prototypes were highly transparent in the visible range, with the H85P15 formulation showing ∼93% light transmission, physiological wettability (contact angle ∼77°), and gel fractions >97%. MB release from commercial and printed lenses was quantified spectrophotometrically and fitted with classical kinetic models. Across all materials, release was best described by the Korsmeyer-Peppas model, indicating anomalous diffusion, with higher HEMA content promoting faster and more extensive release. Printed hydrogels enabled sustained MB delivery for at least 14 days, substantially longer than commercial lenses. Released MB retained concentration-dependent antioxidant activity against H 2 O 2 , confirming the drug's functional stability. Finally, ex vivo experiments on sheep corneas showed that topically applied MB predominantly localized to the epithelium and anterior stroma without disrupting overall tissue architecture. Together, these results demonstrate that vat-printed HEMA-based hydrogels provide a tunable platform for lens-based ocular drug delivery and redox-active therapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ocular Surface and Contact Lens · Advanced Drug Delivery Systems · Ocular Disorders and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. Challenges and obstacles of ocular pharmacokinetics and drug delivery10.1016/j.addr.2006.07.027 ↗
2. Ocular drug delivery10.1208/s12248-010-9183-3 ↗
3. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses10.1016/j.cis.2015.08.002 ↗
4. Therapeutic contact lenses with polymeric vehicles for ocular drug delivery: a review10.3390/ma11071125 ↗
5. Investigation of releasing therapeutic solutions from soft contact lens surfaces constructed by nanoparticles
6. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month10.1016/j.biomaterials.2013.09.032 ↗
7. Drug-eluting contact lenses: progress, challenges, and prospects10.1116/6.0003612 ↗
8. Sustained bimatoprost release using gold nanoparticles laden contact lenses10.1080/09205063.2021.1927656 ↗
9. Sustained latanoprost release from PEGylated solid lipid nanoparticle-laden soft contact lens to treat glaucoma10.1080/10837450.2021.1999471 ↗
10. Levofloxacin-loaded silicone contact lenses materials for ocular drug delivery10.1177/08853282241312089 ↗
11. Advances in nanoparticles in targeted drug delivery–A review, results in
12. Nanocarriers for cancer-targeted drug delivery10.3109/1061186X.2015.1051049 ↗
13. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses10.3109/03639045.2014.948451 ↗
14. Controlled drug release from contact lenses: a comprehensive review from 1965-present10.1016/S1773-2247(11)50062-0 ↗
15. Aptamer-based liposomes improve specific drug loading and release10.1016/j.jconrel.2017.02.026 ↗
16. Cyclodextrin-based nanoparticles for pharmaceutical applications: a review10.1007/s10311-021-01275-y ↗
17. Soft contact lens biomaterials from bioinspired phospholipid polymers10.1586/17434440.3.2.167 ↗
18. Porous silicone hydrogel interpenetrating polymer networks prepared using a template method for biomedical use10.1002/pi.3053 ↗
19. Soft hydrogels interpenetrating silicone—A polymer network for drug‐releasing medical devices10.1002/jbm.b.33371 ↗
20. Modification of timolol release from silicone hydrogel model contact lens materials using hyaluronic acid10.1097/ICL.0000000000000033 ↗
21. The effect of silicone hydrogel contact lens composition on dexamethasone release10.1177/0885328214521253 ↗
22. Prospects for additive manufacturing in contact lens devices10.1002/adem.202000941 ↗
23. 3D printing of bioactive materials for drug delivery applications10.1080/17425247.2022.2112944 ↗
24. 3D printing technology in customized drug delivery system: current state of the art, prospective and the challenges10.2174/1381612825666190110153742 ↗
25. 3D printing in pharmaceuticals: regulatory perspective10.2174/1381612825666181130163027 ↗
26. The potentials of methylene blue as an anti-aging drug10.3390/cells10123379 ↗
27. Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications10.1016/S1572-1000(05)00097-9 ↗
28. Intravitreally injected methylene blue protects retina against acute ocular hypertension in rats10.1080/02713683.2021.1948062 ↗
29. Identification of ocular surface squamous neoplasia by in vivo staining with methylene blue10.1136/bjophthalmol-2013-303956 ↗
30. Methylene blue alleviates endothelial dysfunction and reduces oxidative stress in aortas from diabetic rats10.1139/cjpp-2018-0119 ↗
31. Methylene blue improves mitochondrial respiration and decreases oxidative stress in a substrate-dependent manner in diabetic rat hearts10.1139/cjpp-2017-0074 ↗
32. Enhanced hydrogen peroxide generation accompanies the beneficial bioenergetic effects of methylene blue in isolated brain mitochondria10.1016/j.freeradbiomed.2014.09.024 ↗
33. Methylene blue reduces neuronal apoptosis and improves blood-brain barrier integrity after traumatic brain injury10.3389/fneur.2019.01133 ↗
34. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue10.1016/j.pneurobio.2011.10.007 ↗
35. Methylene blue protects the isolated rat lungs from ischemia–reperfusion injury by attenuating mitochondrial oxidative damage10.1007/s00408-017-0072-8 ↗
36. Methylene blue prevents neurodegeneration caused by rotenone in the retina10.1007/BF03033307 ↗
37. Methylene blue improves sensorimotor phenotype and decreases anxiety in parallel with activating brain mitochondria biogenesis in mid-age mice10.1016/j.neures.2016.07.006 ↗
38. Antimicrobial photoinactivation with methylene blue of Staphylococcus aureus10.1080/15421406.2020.1859702 ↗
39. In vitro study: methylene blue-based antibacterial photodynamic inactivation of Pseudomonas aeruginosa10.1007/s00253-024-13009-5 ↗
40. Escherichia coli sterilization using a light-emitting diode and methylene blue10.5978/islsm.28_19-OR-05 ↗
41. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis10.1167/iovs.10-5593 ↗
42. Photodynamic therapy using methylene blue, combined or not with gentamicin, against Staphylococcus aureus and Pseudomonas aeruginosa10.1016/j.pdpdt.2020.101810 ↗
43. Effect of rutin as flavonoid compound on photodynamic inactivation against P. aeruginosa and S. aureus10.1016/j.pdpdt.2020.102074 ↗
44. The design of contact lens based ocular drug delivery systems for single-day use: part (I) structural factors, surrogate ophthalmic dyes and passive diffusion studies10.1177/0885328214527776 ↗
45. Cellulose acetate phthalate-based pH-Responsive cyclosporine A-Loaded contact lens for the treatment of dry eye10.3390/ijms24032361 ↗
46. Development of new hybrid casein-loaded PHEMA-PEGDA hydrogels with enhanced mineralisation potential10.3390/ma15030840 ↗
47. 4D-printed photochromic contact lenses for ultraviolet monitoring and protection
48. Drug-eluting silicone hydrogel for therapeutic contact lenses: impact of sterilization methods on the system performance10.1016/j.colsurfb.2017.11.021 ↗
49. The oxygen performance of contemporary hydrogel contact lenses10.1016/S1367-0484(98)80016-7 ↗
50. Crystalline methylthioninium chloride hydrates10.1039/c2cp40128b ↗
51. Oxygen permeability and water content of silicone hydrogel contact lens materials10.1097/OPX.0b013e31804375ed ↗
52. Tear film characteristics during wear of daily disposable contact lenses10.2147/OPTH.S242422 ↗
53. In vitro water wettability of silicone hydrogel contact lenses determined using the sessile drop and captive bubble techniques10.1002/jbm.a.31260 ↗
54. The effect of soft contact lens care products on lens modulus10.1016/j.clae.2010.06.002 ↗
55. Influence of selected ophthalmic fluids on the wettability and hydration of hydrogel and silicone hydrogel contact lenses—in vitro study10.3390/ma15030930 ↗